We analyzed the most recent CMS Quality Payment Program data for all 11,424 general cardiologists, the population the Ambulatory Specialty Model's heart failure cohort draws from. Only 32 of them reported Q377, Functional Status Assessments for Heart Failure, in 2024. Just 273 clinicians reported it across every specialty in American medicine.
Q377 is 1 of the 5 quality measures CMS finalized for mandatory heart failure accountability starting Jan. 1, 2027, a model that shifts participants to individual TIN/NPI accountability. ASM also has a group option only for practices of 15 or fewer clinician and carries two-sided payment risk on Medicare Part B.
Q377 is the only measure in either ASM cohort with no fallback: it's eCQM only, with no MIPS CQM option or registry abstraction path. If structured functional assessment data doesn’t flow from certified EHR technology, the measure can’t be reported.
That's a readiness problem sitting inside a mandatory model 4 months out.
|
The Q377 gap |
|
|
General cardiologists analyzed |
11,424 |
|
Reported Q377 in 2024 |
32, or 0.28% |
|
With no 2024 history on it |
11,392, or 99.72% |
|
Reporting fallback if eCQM infrastructure is missing |
None |
The thesis of this analysis is simple: cardiology is entering individual accountability with essentially no individual reporting history on its own condition. Three pieces of evidence follow.
|
ASM HF quality measure |
Collection type |
2024 history |
Mean points (of 10) |
Operational reality |
|
Q236 Controlling High Blood Pressure |
CQM or eCQM |
49.6% |
8.14 |
The one measure where existing behavior carries over |
|
Q492 Unplanned CV Admissions for HF |
Admin claims |
Computed for 50.2% |
5.41 |
Already being scored, whether anyone likes it or not |
|
Q008 HF Beta-Blocker for LVSD |
CQM or eCQM |
7.0% |
8.29 |
A decade of stable specifications, reported by a twentieth of the cohort |
|
Q005 HF ACE/ARB/ARNI for LVSD |
CQM or eCQM |
3.4% |
8.00 |
Same story, smaller footprint |
|
Q377 Functional Status Assessments for HF |
eCQM only |
0.28% |
9.00 |
The bottleneck: structured EHR data or nothing |
A note on the points column: It describes only the clinicians who reported each measure, and small self-selected groups score high. Q377’s 9.00 reflects 32 practices that built the workflow early, not what the other 11,392 should expect. The one number reflecting the whole distribution is Q492’s 5.41, because nobody selects into a claims measure.
The therapy measures aren’t obscure. Q005 and Q008 have carried the same clinical logic for a decade. They go unreported for a structural reason, which is the next point.
In 2024, 6,627 of these cardiologists reported through a group, 2,833 through an APM entity, and 1,936 as individuals. 83% ride on submissions built by a multispecialty organization, scored on the measures that organization selected:
Primary care measures, chosen by the group, applied to everyone in it, earning 8 or better.
That arrangement has been rational for a decade. A health system reports once, everyone receives the group’s score, and no cardiologist maintains an individual reporting operation.
ASM ends it. It calls for individual TIN/NPI assessment and a fixed condition-specific set, benchmarked only against other clinicians managing heart failure. The measure selection strategy that produced 10 years of comfortable scores is gone. For most ASM participants, so is the group reporting structure that executed it.
Q492, the risk-standardized unplanned cardiovascular admission measure, is computed automatically from claims. In 2024 it was computed for 5,730 general cardiologists — half the cohort.
The CY2027 Proposed Rule proposes scoring Q492 at the individual level. So for half the cohort, 1 of the 5 ASM quality measures already exists in preview form and is mediocre. There’s also no selection strategy to route around it because ASM has no measure selection.
Two caveats:
Neither changes the operational fact: the lone ASM measure with real performance history has an uncomfortable one.
The equation for a cardiology executive is this:
That’s financial exposure with a 4-month fuse. Part of it, the Q377 infrastructure question, can’t be fixed quickly.
Comments on the CY2027 Proposed Rule close Sept. 14, 2026, at www.regulations.gov. The individual scoring of Q492 and the small-practice provision under which any group-level submission overrides every individual submission are both open for comment.
Independent of the final rule, we recommend three actions:
National averages tell you where the cohort is vulnerable. They don't tell you whether your clinicians are.
That’s the analysis we’re offering organizations now. Send us your TIN and NPI roster, and within 2 business days we’ll identify:
There’s no cost or obligation.
Request your ASM analysis
Healthmonix ASM readiness analysis | 2024 CMS QPP data. Analysis based on the CMS 2024 Quality Payment Program Experience Public Use File, the most recent performance year available, and the finalized measure set in CMS' ASM Performance Categories fact sheet.
Measures reported through group and APM entity submissions appear on each clinician in the group, so measure counts overstate hands-on experience if anything. Counts reflect general cardiology nationally, not the ASM-selected subset. MIPS points are earned against national benchmarks and aren't projections of ASM cohort-relative scoring. The full cohort analysis, including all measure-level detail, is available on request.
Healthmonix is a CMS-approved Qualified Registry and Qualified Clinical Data Registry. We help specialty organizations and health systems determine ASM eligibility, evaluate historical cost and quality performance, model financial exposure, and prepare for reporting across ASM, MIPS, MVPs, and the Medicare Shared Savings Program. Contact us at contact@healthmonix.com.